Current trends in vaccine development.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001530:Belgium; D002648:Child; D002675:Child, Preschool; D002677:Chile; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D007231:Infant, Newborn; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000627:therapeutic use; D011051:Poliomyelitis / Q000453:epidemiology / Q000517:prevention & control; D011054:Poliovirus Vaccine, Inactivated / Q000627:therapeutic use; D011055:Poliovirus Vaccine, Oral / Q000627:therapeutic use; D012899:Smallpox / Q000517:prevention & control; D012900:Smallpox Vaccine / Q000627:therapeutic use; D014612:Vaccines / Q000008:administration & dosage / Q000592:standards / Q000600:supply & distribution; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000592:standards / Q000600:supply & distribution
D008458:Measles Vaccine; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D012900:Smallpox Vaccine; D014612:Vaccines; D014613:Vaccines, Attenuated